Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines.
about
Micro-scale devices for transdermal drug deliveryNucleic acid delivery into skin for the treatment of skin disease: Proofs-of-concept, potential impact, and remaining challenges.Hollow copper sulfide nanoparticle-mediated transdermal drug deliveryNeedle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice.Microsecond thermal ablation of skin for transdermal drug delivery.Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.Topical application of Escherichia coli-vectored vaccine as a simple method for eliciting protective immunityEnabling skin vaccination using new delivery technologies.DNA vaccines for non-infectious diseases: new treatments for tumour and allergy.Delivery systems for intradermal vaccinationDelivering vaccines into the skin without needles and syringes.Resealing of electroporation of porcine epidermis using phospholipids and poloxamers.Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticlesGene therapy progress and prospects: the skin--easily accessible, but still far away.The effect of heat on skin permeabilityNeedle-free vaccine delivery.The hairless mouse in skin research.Various carrier system(s)- mediated genetic vaccination strategies against malaria.A physically transient form of silicon electronics.Temperature-induced protein release from water-in-oil-in-water double emulsions.Transdermal drug delivery.Selective removal of stratum corneum by microdermabrasion to increase skin permeability.Transdermal immunization: biological framework and translational perspectives.Novel engineered systems for oral, mucosal and transdermal drug delivery.New Horizons in the Development of Novel Needle-Free Immunization Strategies to Increase Vaccination Efficacy.What is the future of heated transdermal delivery systems?Immunization without needles.
P2860
Q27489779-9C2A9883-0E64-4C07-9351-1EBE2617D4D9Q28085200-EB84E33A-C52B-4D6B-A115-6F4F5D5CB800Q28390390-694E3A1E-6407-45AA-894E-E974F6660915Q30361581-3D8A9065-00E7-43DC-968B-D1F11FD917A2Q30464486-C5327216-E19E-4F82-A8D4-CBD298F03D04Q33664783-EDAC7DF8-B2F0-4FD3-8BF9-1BE2C38DCBD6Q34681152-DCBE1AF3-3F46-479D-B020-42EBCE81CFF6Q35126354-66BC32E1-C454-45B4-ADD9-A2C3AC6229F4Q35164804-0185F76C-CC0D-445A-B941-7B2C26C92DD6Q35214379-E42D070F-EE73-4D28-9B1C-450C94F933FDQ35623375-8B86044B-7D70-4043-B185-5500CBB5D2C8Q36088989-3577A41C-8BBE-42A1-A222-2147ACC3114EQ36339297-B6BFCD8F-CFC7-4776-BF48-4DF94618FFC3Q36587586-4DCC6F92-04BE-4422-A3D7-25EC79C4AB97Q36766660-47F8CBCF-7AD2-48FE-BA64-0307FDA89B18Q36945838-A4203ED5-2990-49EB-9572-9531C2360AD0Q37106811-8681C436-CAE8-4D46-A2C5-1ABA93FF2A9AQ37150329-08B525DE-FD3B-426F-B8B6-777E5A15C3FBQ37206408-8C641A23-8FF1-4F53-B3A5-A5829296CC8BQ37216510-48FB2005-31B4-481D-9BD9-BA1112E98B2DQ37238479-A03C37CA-9987-4A62-9E94-4D5E283E09CEQ37316218-A96732D8-8C5A-4F20-90CF-3FD590AAA9AFQ38068975-6F44CB70-6B9D-4435-BD9B-97F4448887CEQ38122744-EF8CA897-DA9C-4DAF-B72A-95E1418FADFFQ38883770-5C5000E3-C4DC-436C-9368-310F901C5EBBQ46195057-4F63992B-374D-4E25-8C6F-E41D776EFD68Q46308392-DDEF57D3-73EB-4DA6-8450-414BA77BACAF
P2860
Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Enabling topical immunization ...... of adenovirus-based vaccines.
@en
Enabling topical immunization ...... of adenovirus-based vaccines.
@nl
type
label
Enabling topical immunization ...... of adenovirus-based vaccines.
@en
Enabling topical immunization ...... of adenovirus-based vaccines.
@nl
prefLabel
Enabling topical immunization ...... of adenovirus-based vaccines.
@en
Enabling topical immunization ...... of adenovirus-based vaccines.
@nl
P2093
P2860
P356
P1433
P1476
Enabling topical immunization ...... of adenovirus-based vaccines.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3301886
P577
2003-02-01T00:00:00Z